These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11183756)

  • 1. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to liver-stage parasites: implications for vaccine development.
    Hollingdale MR; Krzych U
    Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines against asexual stage malaria parasites.
    Kumar S; Epstein JE; Richie TL
    Chem Immunol; 2002; 80():262-86. PubMed ID: 12058644
    [No Abstract]   [Full Text] [Related]  

  • 4. Transmission-blocking vaccines: uses and current status of development.
    Kaslow DC
    Int J Parasitol; 1997 Feb; 27(2):183-9. PubMed ID: 9088989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'do unto others' malaria vaccine.
    Vogel G
    Science; 2010 May; 328(5980):847-8. PubMed ID: 20466919
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria vaccine raises a dilemma.
    Maurice J
    Science; 1995 Jan; 267(5196):320-3. PubMed ID: 7824925
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosquito stage, transmission blocking vaccines for malaria.
    Saul A
    Curr Opin Infect Dis; 2007 Oct; 20(5):476-81. PubMed ID: 17762780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporozoite antigens: biology and immunology of the circumsporozoite protein and thrombospondin-related anonymous protein.
    Sinnis P; Nardin E
    Chem Immunol; 2002; 80():70-96. PubMed ID: 12058652
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid malaria vaccines. Current status and potential.
    Hoffman SL; Doolan DL; Sedegah M; Gramzinski R; Wang H; Gowda K; Hobart P; Margalith M; Norman J; Hedstrom RC
    Ann N Y Acad Sci; 1995 Nov; 772():88-94. PubMed ID: 8546416
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.
    Saxena AK; Wu Y; Garboczi DN
    Eukaryot Cell; 2007 Aug; 6(8):1260-5. PubMed ID: 17557884
    [No Abstract]   [Full Text] [Related]  

  • 15. Malaria vaccines: multiple targets.
    Nussenzweig RS; Long CA
    Science; 1994 Sep; 265(5177):1381-3. PubMed ID: 8073276
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
    Carvalho LJ; Daniel-Ribeiro CT; Goto H
    Scand J Immunol; 2002 Oct; 56(4):327-43. PubMed ID: 12234254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Achievements and problems in the development of malaria vaccines].
    Martínez-Gómez F
    Rev Latinoam Microbiol; 1993; 35(3):319-25. PubMed ID: 8047736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria vaccine design: immunological considerations.
    Good MF; Doolan DL
    Immunity; 2010 Oct; 33(4):555-66. PubMed ID: 21029965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccine against malaria: a long way to go.
    Tuteja R
    Crit Rev Biochem Mol Biol; 2002; 37(1):29-54. PubMed ID: 11905546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.